BlackRock Portfolio holdings
AUM
$5.23T
1-Year Return
24.48%
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
This Quarter Return
-17.56%
1 Year Return
+24.48%
3 Year Return
+103%
5 Year Return
+187.44%
10 Year Return
+430.33%
AUM
$2.03T
AUM Growth
-$561B
(-22%)
Cap. Flow
+$1.59B
Cap. Flow
% of AUM
0.08%
Top 10 Holdings %
Top 10 Hldgs %
17.78%
Holding
5,099
New
121
Increased
1,857
Reduced
2,479
Closed
149
Top Buys
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$1.53B |
| 2 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$1.09B |
| 3 |
Prologis
PLD
|
+$931M |
| 4 |
SPDR Gold Trust
GLD
|
+$798M |
| 5 |
Centene
CNC
|
+$777M |
Top Sells
| 1 |
LPT
Liberty Property Trust
LPT
|
+$1.24B |
| 2 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$1.19B |
| 3 |
MDCO
Medicines Co
MDCO
|
+$1.03B |
| 4 |
Apple
AAPL
|
+$785M |
| 5 |
AT&T
T
|
+$561M |
Sector Composition
| 1 | Technology | 20.34% |
| 2 | Healthcare | 15.21% |
| 3 | Financials | 12.82% |
| 4 | Consumer Discretionary | 9.83% |
| 5 | Communication Services | 8.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Scansource
SCSC
$974M
| $97.3M | ﹤0.01% |
4,548,889
-255,879
| -5% | -$5.47M |
|
|
CVET
1652
DELISTED
Covetrus, Inc. Common Stock
CVET
| $97.2M | ﹤0.01% |
11,938,991
-314,612
| -3% | -$2.56M |
|
1653
Plug Power
PLUG
$1.76B
| $97.1M | ﹤0.01% |
27,423,760
+5,883,362
| +27% | +$20.8M |
|
1654
Texas Capital Bancshares
TCBI
$3.98B
| $97.1M | ﹤0.01% |
4,377,762
-114,339
| -3% | -$2.53M |
|
1655
Appian
APPN
$2.28B
| $96.7M | ﹤0.01% |
2,404,379
-22,650
| -0.9% | -$911K |
|
|
SAIL
1656
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
| $96.2M | ﹤0.01% |
6,322,492
+48,139
| +0.8% | +$733K |
|
1657
Mercury Insurance
MCY
$4.4B
| $96.2M | ﹤0.01% |
2,362,330
-62,660
| -3% | -$2.55M |
|
1658
Consumers Staples Select Sector SPDR Fund
XLP
$16B
| $96M | ﹤0.01% |
1,762,521
+424,575
| +32% | +$23.1M |
|
1659
Artivion
AORT
$1.92B
| $95.9M | ﹤0.01% |
5,670,703
-170,529
| -3% | -$2.89M |
|
1660
HealthStream
HSTM
$855M
| $95.9M | ﹤0.01% |
4,004,218
-90,679
| -2% | -$2.17M |
|
1661
Mueller Water Products
MWA
$3.91B
| $95.8M | ﹤0.01% |
11,961,099
+89,209
| +0.8% | +$715K |
|
1662
Greif
GEF
$3.59B
| $95.7M | ﹤0.01% |
3,076,792
-27,188
| -0.9% | -$845K |
|
1663
iShares ESG Aware MSCI USA ETF
ESGU
$14.5B
| $95.3M | ﹤0.01% |
1,658,108
+1,034,310
| +166% | +$59.5M |
|
1664
Allogene Therapeutics
ALLO
$251M
| $95.3M | ﹤0.01% |
4,902,584
-122,188
| -2% | -$2.38M |
|
1665
Avis
CAR
$5.47B
| $95.3M | ﹤0.01% |
6,856,250
-317,101
| -4% | -$4.41M |
|
|
NXRT
1666
NexPoint Residential Trust
NXRT
$858M
| $95.3M | ﹤0.01% |
3,778,921
+1,199,862
| +47% | +$30.2M |
|
1667
O-I Glass
OI
$1.99B
| $95.1M | ﹤0.01% |
13,380,430
-389,763
| -3% | -$2.77M |
|
1668
Jack in the Box
JACK
$350M
| $95M | ﹤0.01% |
2,709,145
-219,490
| -7% | -$7.69M |
|
|
AAWW
1669
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $94.6M | ﹤0.01% |
3,686,377
-132,943
| -3% | -$3.41M |
|
1670
Bankunited
BKU
$2.96B
| $94.4M | ﹤0.01% |
5,048,642
+108,192
| +2% | +$2.02M |
|
|
TPTX
1671
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $94.3M | ﹤0.01% |
2,110,869
-19,962
| -0.9% | -$891K |
|
1672
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$15.1B
| $94M | ﹤0.01% |
1,678,590
+43,677
| +3% | +$2.45M |
|
1673
Marcus & Millichap
MMI
$1.26B
| $94M | ﹤0.01% |
3,467,243
-64,692
| -2% | -$1.75M |
|
|
RDFN
1674
DELISTED
Redfin
RDFN
| $93.9M | ﹤0.01% |
6,090,107
-15,744
| -0.3% | -$243K |
|
1675
Vanda Pharmaceuticals
VNDA
$266M
| $93.8M | ﹤0.01% |
9,054,848
-331,033
| -4% | -$3.43M |
|